Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Jennifer L. Taubert

At a glance: Jennifer L. Taubert is Evp, Wwc. Innovative Medicine at Johnson & Johnson (JNJ). Their latest SEC Form 4, filed Aug 18, 2026, reported a sale of $4.0M. On file: 0 purchase lines ($0) and 1 sale line ($4.0M).

Disclosed holdings: about $51.9M of JNJ stock: 194,451 shares reported on their latest Form 4 (filed Aug 18, 2026), valued at the Nov 19, 2026 close of $267.11. This counts only JNJ shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Evp, Wwc. Innovative Medicine at Johnson & Johnson (JNJ)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.0M

Reported trades

Filed Stock Type Shares Price Value Since
Aug 18SEC JNJJohnson & Johnson Sell 15,000194,451 held (−7%) $263.36 $4.0M +1.4%

Follow Jennifer L. Taubert

Get one email when Jennifer L. Taubert files a new purchase or sale. Free.

At most one email a day about Jennifer L. Taubert, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.